Scheduling of measles vaccination in low-income countries: Projections of a dynamic model

Vaccine

Volumn 27, Issue 31, 2009, Pages 4090-4098

  Bauch, C T ^a   Szusz, E ^a   Garrison, L P ^b  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Compartmental model; Dynamic model; Global health; Measles vaccine; Second opportunity; Supplementary immunization activities

Indexed keywords

ANTIBODY; MEASLES VACCINE;

AGE; ARTICLE; CAMBODIA; COMPARTMENT MODEL; CORRELATION ANALYSIS; DEVELOPING COUNTRY; EPIDEMIOLOGICAL DATA; GHANA; HUMAN; INCIDENCE; INDIA; MEASLES; MEASLES VACCINATION; MOROCCO; NIGERIA; PRIORITY JOURNAL; PROBABILITY; PUBLIC HEALTH; UGANDA; UNCERTAINTY;

DEVELOPING COUNTRIES; DISEASE OUTBREAKS; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; IMMUNIZATION SCHEDULE; MEASLES; MEASLES VACCINE; MODELS, THEORETICAL;

EID: 67349168121     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.079     Document Type: Article

References (49)

1. Wolfson L.J., Strebel P.M., Gacic-Dobo M., Hoekstra E.J., McFarland J.W., and Hersh B.S. Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. The Lancet 369 (2007) 191-200
2. MIC. Measles Investment Case II Report; 2005.
3. Pasetti M.F., Resendiz-Albor A., Ramirez K., Stout R., Papania M., Adams R.J., et al. Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in Rhesus Macaques. Clinical Pharmacology and Therapeutics 82 6 (2007) 672-685
4. Cutts F., Clements C., and Bennett J. Alternative routes of measles immunization: a review. Biologicals 25 3 (1997) 323-338
5. Burger J.L., Cape S.P., Braun C.S., McAdams D.H., Best J.A., Bhagwat P., et al. Stabilizing formulations for inhalable powders of live-attenuated measles virus vaccine. Journal of Aerosol Medicine and Pulmonary Drug Delivery 21 1 (2008) 25-34
6. Aguado M., and Henao-Restrepo A. New measles vaccine formulations and delivery systems and their potential contribution to reducing measles mortality worldwide. Vaccines preventing disease and protecting health (2003), Pan American Health Organization p. 43-52
7. Hethcote H. The mathematics of infectious diseases. SIAM Review 42 4 (2000) 599-653
8. Anderson R., and May R. Infectious diseases of humans (1991), Oxford University Press, Oxford
9. Edmunds W., Medley G., and Nokes D. Evaluating the cost-effectiveness of vaccination programs: a dynamic perspective. Statistics in Medicine 18 23 (1999) 3263-3282
10. Schenzle D. An age-structured model of pre- and post-vaccination measles transmission. Mathematical Medicine and Biology: A Journal of the IMA 1 (1984) 169-191
11. Babad H., Nokes D., Gay N., Miller E., Morgan-Capner P., and Anderson R. Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiology and Infection 114 2 (1995) 319-344
12. Bauch C., and Earn D. Transients and attractors in epidemics. Proceedings of the Royal Society of London Series A 270 (2003) 1573-1578
13. McLean A., and Anderson R. Measles in developing countries. Part I. Epidemiological parameters and patterns. Epidemiology and Infection 100 1 (1988) 111-133
14. Nokes D., McLean A., Anderson R., and Grabowsky M. Measles immunization strategies for countries with high transmission rates: interim guidelines predicted using a mathematical model. International Journal of Epidemiology 19 (1990) 703-710
15. Agur Z., Cojocaru L., Mazo G., Anderson R.M., and Danon Y.L. 9 MG. Pulse mass measles vaccination across age cohorts. Proceedings of the National Academy of Sciences of the United States of America 90 (1991) 11698-11702
16. Nokes D., and Swinton J. Vaccination in pulses: a strategy for global eradication of measles and polio?. Trends in Microbiology 5 1 (1997) 14-19
17. MOH. Modelling measles: predicting and preventing measles epidemics in New Zealand. Application of a mathematical model (1998), Ministry of Health of New Zealand
18. Ferrari M.J., Grais R.F., Bharti N., Conlan A.J., Bjørnstad O.N., Wolfson L.J., et al. The dynamics of measles in sub-Saharan Africa. Nature 451 (2008) 679-684
19. Grenfell B., Bjornstad O., and Kappey J. Travelling waves and spatial hierarchies in measles epidemics. Nature 414 (2001) 716-723
20. Hartter H., Oyedele O., Dietz K., Kreis S., Hoffman J., and Muller C. Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children. Pediatric Infectious Diseases Journal 19 (2000) 635-641
21. Janaszek W., and Slusarczyk J. Immunity against measles in populations of women and infants in Poland. Vaccine 21 (2003) 2948-2953
22. UN; 2008 [cited 2008 24 April]. Available from: http://esa.un.org/unpp.
23. Mossong J., and Muller C. Modelling measles re-emergence as a result of waning immunity in vaccinated populations. Vaccine 21 (2003) 4597-4603
24. Mossong J., Nokes D., Edmunds W., Cox M., Ratnam S., and Muller C. Modeling the impact of sublinical measles transmission in vaccinated populations with waning immunity. American Journal of Epidemiology 150 11 (1999) 1238-1249
25. Remme J., Mandara M., and Leeuwenburg J. The force of measles infection in East Africa. International Journal of Epidemiology 13 3 (1984) 332-339
26. Assaad F. Measles: summary of worldwide impact. Reviews of Infectious Diseases 5 3 (1983) 452-459
27. Perry R., and Halsey N. The clinical significance of measles: a review. The Journal of Infectious Diseases 189 (2004) S4-S16
28. WHO; 2008 [cited 2008 24 April]. Available from: http://www.who.int/immunization_monitoring/data/en.
29. Hull H., Williams P., and Oldfield F. Measles mortality and vaccine efficacy in rural West Africa. The Lancet 1 April (8331) (1983) 972-975
30. MP. The measles partnership; 2008 [cited 2008 24 April]. Available from: http://www.measlesinitiative.org.
31. Grais R.F., Dubray C., Gerstl S., Guthmann J.P., Djibo A., Nargaye K.D., et al. Unacceptably high mortality related to measles epidemics in Niger, Nigeria and Chad. PLoS Medicine 4 1 (2007) e16
32. Stein C., Birmingham M., Kurian M., Duclos P., and Strebel P. The global burden of measles in the year 2000-a model that uses country-specific indicators. The Journal of Infectious Diseases 187 Suppl. 1 (2003) S8-S14
33. Kremer J., Schneider F., and Muller C. Waning antibodies in measles and rubella vaccinees-a longitudinal study. Vaccine 24 (2006) 2594-2601
34. Collier L., and Oxford J. Human virology. 3rd edition (2006), Oxford University Press
35. AAP. Measles. In: Pickering L. (Ed). Red Book: 2006 Report of the Committee on infectious diseases. 27 edition (2006), American Academy of Pediatrics, Elk Grove Village, IL 441-452
36. Coronado F., Musan N., Tayeb E., Haithami S., Dabbagh A., and Mahoney F. Retrospective measles outbreak investigation: Sudan, 2004. Journal of Tropical Pediatrics 52 5 (2006) 329-334
37. Otten M., Okwo-Bele J., and Kezaala R. Impact of alternative approaches to accelerated measles control: experience in the African region, 1996-2002. Journal of Infectious Diseases 187 Suppl. 1 (2003) S36-43
38. Dollimore N., Cutts F., Binka F., Ross D., Morris S., and Smith P. Measles incidence, case fatality, and delayed mortality in children with or without vitamin A supplementation in rural Ghana. American Journal of Epidemiology 146 8 (1997) 646-654
39. Nandy R., Handzel T., Zaneidou M., Biey J., Coddy R.Z., Perry R., et al. Case-fatality rate during a measles outbreak in eastern Niger in 2003. Clinical Infectious Diseases 42 (2003) 322-328
40. Samb B., Aaby P., Whittle H., Seck A., and Simondon F. Protective efficacy of high-titre measles vaccines administered from the age of five months: a community study in rural Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene 87 (1993) 697-701
41. Lennon J., and Black F. Maternally derived measles immunity in era of vaccine-protected mothers. Journal of Pediatrics 108 5 (1986) 671-676
42. Szenborn L., Tischer A., Pejcz J., Rudkowski Z., and Wojcik M. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers. Medical Sciences Monitoring 9 12 (2003) CR541-CR546
43. Farrington C., and Whitaker H. Contact surface models for infectious diseases: estimation from serologic survey data. Journal of the American Statistical Association 100 470 (2005) 370-379
44. Dabbagh A., Gacic-Dobo M., Feathersone D., Strebel P., and Owko-Bele J. Progress in global measles control and mortality reduction, 2000-2006. JAMA 299 4 (2008) 400-402
45. Wallinga J., Heijne J., and Kretzschmar M. A measles epidemic threshold in a highly vaccinated population. PLoS Medicine 2 11 (2005) e316
46. Earn D., Rohani P., Bolker B., and Grenfell B. A simple model for complex dynamical transitions in epidemics. Science 287 (2000) 667-670
47. Hethcote H., and Ark H.V. Epidemiological models for heterogeneous populations: proportionate mixing, parameter estimation and immunization programs. Mathematical Biosciences 84 11 (1987) 85-118
48. Rohani P., Earn D., and Grenfell B. Opposite patterns of synchrony in sympatric disease metapopulations. Science 286 (1999) 968-971
49. Beutels P., and Gay N. Economic evalution of options for measles vaccination in a hypothetical Western European country. Epidemiology and Infection 130 (2003) 273-283